Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting Wegovy in the UK is straightforward in principle but involves a few genuine steps — because it is a prescription-only medicine, meaning a qualified clinician has to assess whether it is right for you before any treatment is dispensed. That assessment is not a formality; it is a legal requirement and, more importantly, a safety one. Whether you go through the NHS or a regulated private service like nume, the route starts with a clinical conversation, not a checkout. The process itself is not especially difficult for most people who meet the licensed criteria, but it does take longer via the NHS than many expect — and the distinction matters when you are trying to decide which route makes sense.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people arrive at this question after hearing that Wegovy is available on the NHS. That is true, but the practical picture is more complicated. NICE recommends semaglutide for weight management only when it is used for a maximum of two years, within a specialist weight management service that provides multidisciplinary support, and for adults with a BMI of at least 35 alongside at least one weight-related health condition. Lower thresholds can apply for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. Those criteria are described in full in NICE's technology appraisal TA875.
Meeting the criteria on paper does not mean access is immediate. Referral to a specialist service is the first step, and waiting lists in many parts of England run into months. Scotland, Wales and Northern Ireland commission services differently, so availability varies further. There is also no guarantee that a given local service has capacity. For people who genuinely qualify but find the wait long, the NHS route can feel anything but straightforward. That gap is why regulated private services exist.
One misconception worth letting go of gently: Wegovy is not available over the counter or as a direct purchase. Every legitimate supply requires a prescription following a clinical review. Sellers who suggest otherwise are not operating within UK law, and the MHRA has repeatedly warned about counterfeit weight-loss pens circulating online.
For most people who meet the licensed eligibility criteria, a regulated private pharmacy is the faster route. The process is still clinical (that does not change) but the waiting list does not exist. At a service like nume, you complete a free online consultation, which a GPhC-registered Independent Prescriber reviews personally the same day. No algorithm makes the call; a real clinician reads your answers.
If the prescriber is satisfied that Wegovy is clinically appropriate, a prescription is issued and treatment is dispatched the same working day for orders placed before noon, arriving by tracked DPD delivery the next working day in plain packaging. The eligibility bar is the licensed SmPC standard: adults with a BMI of 30 or above, or 27 or above with a qualifying condition such as hypertension, type 2 diabetes, dyslipidaemia or obstructive sleep apnoea. BMI alone does not guarantee a prescription, the prescriber weighs the full picture, including any contraindications.
You can verify any online pharmacy on the GPhC's public register before you share any health information with them. It takes under a minute and is one of the most reliable checks available.
Practically speaking, getting Wegovy through a private licensed route involves: a health questionnaire covering your BMI, medical history, current medicines and relevant conditions; identity verification; and, for some services, live weight verification. Once the prescriber approves, your treatment arrives, and the process repeats at each repeat, because every order is reviewed again rather than sent automatically.
The titration schedule is fixed by the prescriber and the medicine's licence: treatment starts at a low dose and is increased gradually over several months. Semaglutide, the active ingredient in Wegovy, works as a GLP-1 receptor agonist, it acts on appetite signals and slows gastric emptying, helping people eat less without the constant battle against hunger. The clinical trial programme published in the New England Journal of Medicine (STEP 1, 2021) reported an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, alongside a reduced-calorie diet and increased activity.
Side effects are mostly gastrointestinal (nausea, loose stools, constipation, indigestion) and tend to be most noticeable in the first weeks after starting or after a dose step. They settle for most people. If you want to understand them before deciding, our frequently asked questions cover the common concerns in plain terms, including how Wegovy can affect your skin's sensitivity to sunburn. For a broader look at how private treatment compares on cost, the Wegovy price comparison page gives a factual run-through of what to expect.
Getting started is one question; stopping or pausing Wegovy is another that comes up more than you might think, whether because of side effects, a planned surgery, pregnancy, or simply deciding the timing is not right. That is always a conversation for your prescriber rather than a unilateral decision, because stopping abruptly can affect how your body responds. Similarly, if you are transferring from another service, a regulated pharmacy will ask for evidence of your current dose and recent treatment before continuing, that is standard clinical practice, not bureaucracy for its own sake.
If you are starting from scratch and want to understand the full private process before committing, a step-by-step guide to getting Wegovy walks through what to expect at each stage. And if you are still weighing up which treatment might suit you, our weight-loss treatment overview covers the licensed options side by side. The consultation itself is free and carries no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.